A recent pilot study saw an automated 3D cell imaging platform called Cell-CT non-invasively detect the presence or absence of lung cancer in sputum samples collected from patients. In the pilot, researchers collected and studied sputum samples from lung cancer patients and from healthy patients. VisionGate's Cell-CT platform and LuCED sputum test creates 3D images of the cells contained in the sputum and uses advanced algorithms and image analysis software to make a cell-based diagnostic approach. >>>Read more.